Who owns GT BIOPHARMA INC COM NEW?
- Ticker: GTBP
- CUSIP Number: 36254l308
Tip: Access positions for across all investors
Analyze quarterly positions in Gt Biopharma with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Gt Biopharma stock
Who bought or sold GT BIOPHARMA INC COM NEW this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Scientech Research | 55k | $43k | 100% | Dec 2025 |
|
| SeaCrest Wealth Management | 50k | $37k | 100% | Dec 2025 |
|
| Citadel Advisors | 40k | $24k | 100% | Sep 2025 |
|
| Jane Street | 26k | $20k | 100% | Dec 2025 |
|
| Integrated Wealth Concepts | 20k | $16k | 100% | Dec 2025 |
|
| Geode Capital Management | 19k | $15k | -20% | Dec 2025 |
|
| Coston, McIsaac & Partners | 17k | $13k | 100% | Dec 2025 |
|
| Caitlin John | 17k | $13k | 100% | Dec 2025 |
|
| Wells Fargo & Company | 16k | $13k | 60% | Dec 2025 |
|
| HPM Partners | 15k | $12k | 100% | Dec 2025 |
|
| Am Investment Strategies | 15k | $12k | 100% | Dec 2025 |
|
| Verdence Capital Advisors | 13k | $10k | 100% | Dec 2025 |
|
| Two Sigma Securities | 13k | $9.8k | -27% | Dec 2025 |
|
| Prospera Financial Services | 12k | $9.4k | 100% | Dec 2025 |
|
| Hrt Financial | 12k | $9.0k | 100% | Dec 2025 |
|
| Parsons Capital Management | 11k | $8.6k | 100% | Dec 2025 |
|
| LPL Financial | 11k | $8.3k | 100% | Dec 2025 |
|
| Advisory Services Network | 10k | $7.9k | 100% | Dec 2025 |
|
| HBK Sorce Advisory | 10k | $5.4k | 100% | Dec 2025 |
|
| BlackRock | 8.4k | $6.6k | -14% | Dec 2025 |
|
| Wolff Wiese Magana | 5.0k | $3.9k | 100% | Dec 2025 |
|
| Newbridge Financial Services Group | 3.8k | $2.9k | 0% | Dec 2025 |
|
| Farther Finance Advisors | 3.0k | $2.4k | 100% | Dec 2025 |
|
| Atlantic Trust | 2.0k | $1.6k | 100% | Dec 2025 |
|
| Advisor Group Holdings | 2.0k | $1.6k | -61% | Dec 2025 |
|
| Tower Research Capital | 1.7k | $1.3k | 0% | Dec 2025 |
|
| Triumph Capital Management | 1.7k | $1.3k | 100% | Dec 2025 |
|
| SWAN Capital | 1.0k | $785.000000 | 100% | Dec 2025 |
|
| Spire Wealth Management | 994.00 | $784.961800 | 100% | Dec 2025 |
|
| Bnp Paribas Arbitrage, Snc | 16.00 | $13.000000 | 0% | Dec 2025 |
|
| UBS Group | 1.00 | $1.000000 | -100% | Dec 2025 |
|
| Hanson McClain Advisors | 1.00 | $1.000000 | 0% | Dec 2025 |
|
| SBI Securities | 1.00 | $1.000000 | -80% | Dec 2025 |
|
| Jpmorgan Chase & Co | 1.00 | $1.000000 | 100% | Sep 2025 |
|
Who sold out of Gt Biopharma?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| DRW Holdings | Sep 2025 | 142k | $84k |
| Vanguard Group | Sep 2025 | 11k | $6.2k |
| Hartland & Co | Sep 2025 | 865.00 | $508.014500 |
| Jones Financial Companies, L.L | Sep 2025 | 300.00 | $230.010000 |
| Blue Bell Private Wealth Management | Sep 2025 | 10.00 | $6.000000 |